Janette Roper 's Entries

1 blog
  • 16 Aug 2018
    Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably protected for use - and failure to perform so may possibly be grounds for compensation. Our lawyers are working hard to acquire those hurt by the drug the compensation they may be entitled to.Even though bleeding is actually a frequent complication linked with anticoagulants, it has been alleged that Xarelto is much more unsafe than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, individuals might be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.In case you or a loved one suffered a severe bleeding occasion after taking Xarelto, you may have legal recourse. For much more data, get in touch with us these days to have your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Additionally, they are seeking punitive damages, which are typically awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects Can xarelto cause joint Pain be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a protected anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for far more info on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    154 Posted by Janette Roper
  • Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably protected for use - and failure to perform so may possibly be grounds for compensation. Our lawyers are working hard to acquire those hurt by the drug the compensation they may be entitled to.Even though bleeding is actually a frequent complication linked with anticoagulants, it has been alleged that Xarelto is much more unsafe than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, individuals might be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.In case you or a loved one suffered a severe bleeding occasion after taking Xarelto, you may have legal recourse. For much more data, get in touch with us these days to have your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Additionally, they are seeking punitive damages, which are typically awarded to punish the defendant and deter other businesses from acting similarly.Why Are Lawsuits Being Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects Can xarelto cause joint Pain be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a protected anticoagulant option.Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.Visit this page for far more info on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    Aug 16, 2018 154